View Single Post
Old 03-27-2010, 03:55 PM   #1
Christine MH-UK
Senior Member
 
Join Date: Sep 2005
Posts: 414
CEP17 seems to be key to anthracycline susceptibility

I figured that this one is a pretty important answer to a pretty major question: who actually benefits from those potentially cardiotoxic anthracyclines.

http://www.eurekalert.org/pub_releas...-nwd032410.php

As someone who had a very minimal response to anthracyclines and an unusually high level of side effects, I am glad to see that a charity I support Cancer Research UK, has helped answer this question. Might even send them a well done letter!
Christine MH-UK is offline   Reply With Quote